Keyphrases
Advanced Breast Cancer
100%
Intrinsic Effect
100%
Gemcitabine
100%
Breast Cancer Patients
100%
Docetaxel
83%
Basal-like
66%
Overall Survival
50%
Time to Progression
50%
Intrinsic Subtype
33%
Chemotherapy
16%
Response Rate
16%
Kaplan-Meier Method
16%
Overall Response Rate
16%
Independent Prognostic Factor
16%
Formalin-fixed Paraffin-embedded Tissue
16%
Randomized Clinical Trial
16%
Breast Cancer
16%
Cox Proportional Hazards Regression Model
16%
Hazard Ratio
16%
In Vitro Study
16%
Overall Survival Rate
16%
HER2-enriched
16%
Confidence Interval
16%
Cooperative Group
16%
Survival Events
16%
Luminal B
16%
Clinically Significant
16%
Statistical Analysis
16%
Statistical Test
16%
Primary Breast Tumor
16%
Significant Predictors
16%
Medicine and Dentistry
Gemcitabine
100%
Breast Cancer
100%
Docetaxel
83%
Overall Survival
66%
Hazard Ratio
16%
Proportional Hazards Model
16%
Randomized Clinical Trial
16%
Breast Tumor
16%
Prognostic Factor
16%
Clinical Trial
16%
Arm
16%
In Vitro
16%
Formaldehyde
16%
Basal Like Breast Cancer
16%
Kaplan Meier Method
16%
Biochemistry, Genetics and Molecular Biology
Gemcitabine
100%
Overall Survival
66%
RNA
33%
Subtyping
16%
Randomized Clinical Trial
16%
In Vitro Study
16%
Clinical Trial
16%
Statistical Test
16%